BioXcel Therapeutics (BTAIQ) Revenue (2018 - 2026)
BioXcel Therapeutics (BTAIQ) recorded Revenue of $182,000 in Q2 2026, up 51.7% from $120,000 a year earlier but down 11.7% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Revenue (2018 - 2026) Analysis & Trends
On a TTM basis, BioXcel Therapeutics' Revenue came in at $742,000 as of Jun 30, 2026, down 14.5% year-over-year; for FY2025, it came in at $642,000, down 71.7% from FY2024.
- Annual Revenue has a three-year compound annual growth rate of 19.6% (FY2022 to FY2025).
- Across earlier years, Revenue came in at $2.27 million in FY2024 (+64.2%), $1.38 million in FY2023 (+268.0%) and $375,000 in FY2022.
- Quarterly Revenue has ranged from $98,000 in Q3 2025 to $1.1 million in Q2 2024 over the past five years.
- On a year-over-year basis, Revenue rose in two of the last eight quarters, with an average decline of 26.3%.
- Peak year-over-year performance for Revenue in the last five years was growth of 182.5% in Q1 2024, against a decline of 89.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $206,000 (Q1 2026), $256,000 (Q4 2025) and $98,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | BioXcel Therapeutics | 381,780.00 | -94.23 Mn | 160,000.00 | 182,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 341,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 85,000.00 |
| Dec 31, 2019 | 138,000.00 |
API Access
BioXcel Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();